As the healthcare industry continues adjusting to the increasing diagnosis of lifestyle-related diseases and demand for affordable care, effective surgical procedures assisted by robotic devices and a decline in treatment costs look promising. Next-generation surgical robotic technology platforms complement and extend surgeons’ ability to minimize surgical variability, a key factor driving adoption of robotic-assisted surgical device (RASD) platforms among hospitals, as now surgeons can perform complex tasks with greater control and less strain while ensuring patient safety.
The need to gain experience before robotic-assisted surgery remains debatable; however, the transition from a laparoscopic surgeon to a robotic surgeon is associated with a shorter learning period. Hence, several medical and research institutes in the United States and Europe now offer robotic surgery training programs to ensure more surgeons have the expertise and skills needed, but with a shorter learning curve.
With the advancement of digital and analytical technologies, deployment of artificial intelligence (AI) technologies, including machine learning and machine vision, in next-generation surgical platforms enables the systems to offer insights to surgeons based on analysis of the data collected. Moreover, haptic feedback signals when the pressure threshold is reached as a way to prevent damaging anatomical structures.
Partnerships between next-generation surgical robotic platform manufacturers and software developers; use of flexible payment and leasing business models; and focus on improved ergonomics, multi-quadrant surgeries, and reduced surgeon burnout and occupation-related disease acquisition are the key trends in this area. Frost & Sullivan believes that the adoption of next-generation surgical robotic technology platforms will increase inpatient surgery volumes by reducing patients’ length of stay (LOS) and thus offer a significant cost advantage for hospitals.
Surgical robot vendors and manufacturers must create a robust pipeline of RASD that will empower healthcare organizations with digital health tools and capabilities, including secure data storage, data interoperability, and networking.
In a field of about 40 industry participants, Frost & Sullivan independently plotted in this Frost Radar™ analysis the top 13 companies that generated revenue from robotic platforms between 2018 and 2021 and are actively marketing, installing, and developing next-generation surgical robotic technology platforms. The Frost Radar™ reveals the market positioning of each company using their Growth and Innovation scores as highlighted in the Frost Radar™ methodology. The document presents competitive profiles based on the companies’ strengths, opportunities, and a small discussion on their positioning.
Author: Bejoy Daniel

Strategic Imperative
Strategic Imperative (continued)
Growth Environment
Growth Environment (continued)
Growth Environment (continued)
Growth Environment (continued)
Frost Radar™: Robotic-assisted Surgical Devices Market
Frost Radar™: Competitive Environment
Frost Radar™: Competitive Environment (continued)
Frost Radar™: Competitive Environment (continued)
Frost Radar™: Competitive Environment (continued)
Asensus Surgical
Auris Health
Brainlab
CMR Surgical
Corindus
Globus Medical
Intuitive Surgical
Medtronic
Robocath
Stereotaxis
Smith & Nephew
Stryker
Zimmer Biomet
Strategic Insights
Significance of Being on the Frost Radar™
Frost Radar™ Empowers the CEO’s Growth Team
Frost Radar™ Empowers Investors
Frost Radar™ Empowers Customers
Frost Radar™ Empowers the Board of Directors
Frost Radar™: Benchmarking Future Growth Potential
Frost Radar™: Benchmarking Future Growth Potential
Legal Disclaimer
Frost Radar™: Benchmarking Future Growth Potential 2 Major Indices, 10 Analytical Ingredients, 1 Platform
Growth Index
Growth Index (GI) is a measure of a company’s growth performance and track record, along with its ability to develop and execute a fully aligned growth strategy and vision; a robust growth pipeline system; and effective market, competitor, and end-user focused sales and marketing strategies.
- Market Share (previous 3 years)
This is a comparison of a company’s market share relative to its competitors in a given market space for the previous 3 years. - Revenue Growth (previous 3 years)
This is a look at a company’s revenue growth rate for the previous 3 years in the market/industry/category that forms the context for the given Frost Radar™. - Growth Pipeline
This is an evaluation of the strength and leverage of a company’s growth pipeline system to continuously capture, analyze, and prioritize its universe of growth opportunities. - Vision and Strategy
This is an assessment of how well a company’s growth strategy is aligned with its vision. Are the investments that a company is making in new products and markets consistent with the stated vision? - Sales and Marketing
This is a measure of the effectiveness of a company’s sales and marketing efforts in helping it drive demand and achieve its growth objectives.
Innovation Index
Innovation Index (II) is a measure of a company’s ability to develop products/ services/ solutions (with a clear understanding of disruptive Mega Trends) that are globally applicable, are able to evolve and expand to serve multiple markets and are aligned to customers’ changing needs.
- INNOVATION SCALABILITY
This determines whether an organization’s innovations are globally scalable and applicable in both developing and mature markets, and also in adjacent and non-adjacent industry verticals. - RESEARCH AND DEVELOPMENT
This is a measure of the efficacy of a company’s R&D strategy, as determined by the size of its R&D investment and how it feeds the innovation pipeline. - PRODUCT PORTFOLIO
This is a measure of a company’s product portfolio, focusing on the relative contribution of new products to its annual revenue. - MEGATRENDS LEVERAGE
This is an assessment of a company’s proactive leverage of evolving, long-term opportunities and new business models, as the foundation of its innovation pipeline. - CUSTOMER ALIGNMENT
This evaluates the applicability of a company’s products/services/solutions to current and potential customers, as well as how its innovation strategy is influenced by evolving customer needs.
Significance of Being on the Frost Radar™
Companies plotted on the Frost RadarTM are the leaders in the industry for growth, innovation, or both. They are instrumental in advancing the industry into the future.
- GROWTH POTENTIAL
Your organization has significant future growth potential, which makes it a Company to Action. - BEST PRACTICES
Your organization is well positioned to shape Growth Pipeline™ best practices in your industry. - COMPETITIVE INTENSITY
Your organization is one of the key drivers of competitive intensity in the growth environment. - CUSTOMER VALUE
Your organization has demonstrated the ability to significantly enhance its customer value proposition. - PARTNER POTENTIAL
Your organization is top of mind for customers, investors, value chain partners, and future talent as a significant value provider.
Speak directly with our analytics experts for tailored recommendations.
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Frost Radar |
|---|---|
| Author | Bejoy Daniel |
| GPS Codes | 9600-B1,9A47-B1,9A48-B1,9A49-B1,9A4B-B1 |
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Podcast | No |
| WIP Number | MG82-01-00-00-00 |
Frost Radar™: Global Robotic-assisted Surgical Devices, 2022
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
29-Mar-2022
North America
Frost Radar
